Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Net Income: 2011-2025

Historic Net Income for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to -$883,820.

  • Sunshine Biopharma's Net Income rose 26.21% to -$883,820 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 41.81%. This contributed to the annual value of -$5.1 million for FY2024, which is 13.94% down from last year.
  • As of Q3 2025, Sunshine Biopharma's Net Income stood at -$883,820, which was up 50.09% from -$1.8 million recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Net Income peaked at $667,116 during Q4 2021, and registered a low of -$23.5 million during Q4 2022.
  • For the 3-year period, Sunshine Biopharma's Net Income averaged around -$1.2 million, with its median value being -$1.2 million (2024).
  • Examining YoY changes over the last 5 years, Sunshine Biopharma's Net Income showed a top increase of 161.55% in 2021 and a maximum decrease of 6,461.84% in 2021.
  • Sunshine Biopharma's Net Income (Quarterly) stood at $667,116 in 2021, then plummeted by 3,624.47% to -$23.5 million in 2022, then soared by 94.68% to -$1.3 million in 2023, then slumped by 72.65% to -$2.2 million in 2024, then increased by 26.21% to -$883,820 in 2025.
  • Its Net Income stands at -$883,820 for Q3 2025, versus -$1.8 million for Q2 2025 and -$1.2 million for Q1 2025.